3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Lung Diseases
1
Carcinoma
1
Interventions
Carboplatin
8
Pemetrexed
3
Paclitaxel
3
durvalumab
2
atezolizumab
2
Nivolumab
2
Ipilimumab
2
Cisplatin
2
Bevacizumab
2
zipalertinib
1
toripalimab
1
sotorasib
1
sitravatinib
1
sintilimab
1
pembrolizumab
1
necitumumab
1
demcizumab
1
ceralasertib
1
cemiplimab
1
camrelizumab
1
apatinib
1
aflibercept
1
Toll-Like Receptor 1
1
Radiotherapy
1
Omacor
1
Gemcitabine
1
Etoposide
1
Erlotinib Hydrochloride
1
Diarylheptanoids
1
Diagnostic Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Lung Diseases
×
demcizumab
×
Clear all
NCT02259582
2020-09-09
DENALI
Mereo BioPharma
Phase 2
Completed
82 enrolled
10 charts